Feed 6541.TW
65
Tanvex BioPharma, Inc.
6541.TW · TAI
$37.35 -1.97% (-$0.75)
1M -6.58%
Market Cap $10.1B
P/E Ratio -
Div. Yield -
ROE 27.54%
Valuation
47 /100
Fair P/B 1.78x
P/S 25.21x
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 59.95%
Rev. growth 161.57%
FCF growth N/A
Profitability
0 /100
Weak Net margin 374.13%
Op. margin 346.21%
FCF margin 417.90%
Quality
1 /100
Poor ROE 27.54%
ROA 18.84%
Asset turnover 0.05x
Debt
68 /100
Low Current ratio 1.87x
Int. coverage -29.39x
Debt/Equity 0.28x
Stability
19 /100
Unstable Rev. volatility 582.40%
EPS volatility 35.21%
Profitable years 0
Vprašajte StockBota o 6541.TW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Stephen Lam
Employees
215
Headquarters
George Town
Prihajajoči dogodki
16 NOV.
Earnings
Upcoming earnings report